Interestingly, glioma patients with high TNIP1 levels in all neoplasm tissues, including glioblastoma, oligodendroglioma and astrocytoma, showed significantly shorter survival compared with glioma patients with low TNIP1 levels (Figure 1B,1,1). This evidence concerns the gene TNIP1 and glioblastoma.